Though plasma t-tau was among the earliest blood-based immunoassays used to detect soluble tau in AD, its diagnostic value is limited due to significant overlap in its levels among different diagnostic categories [26, 27]. The gene discussed is MAPT; the disease is Alzheimer disease.